What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Antibody
Donato Alarcón-Segovia focuses on Immunology, Lupus erythematosus, Internal medicine, Antibody and Systemic disease.
The concepts of his Immunology study are interwoven with issues in Autoimmune thyroiditis and Pathology.
Donato Alarcón-Segovia combines subjects such as Systemic lupus erythematosus, Disease, Connective tissue disease and Cohort with his study of Lupus erythematosus.
His studies in Internal medicine integrate themes in fields like Gastroenterology and Surgery.
His work deals with themes such as Cell, Hemolytic anemia, Receptor, Peripheral blood mononuclear cell and Cytotoxic T cell, which intersect with Antibody.
His Systemic disease research is multidisciplinary, incorporating perspectives in Thrombosis and Vasculitis.
His most cited work include:
- A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans (672 citations)
- Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. (575 citations)
- Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. (486 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Immunology, Antibody, Internal medicine, Lupus erythematosus and Autoantibody.
Immunology and Systemic lupus erythematosus are frequently intertwined in his study.
The Antibody study combines topics in areas such as Molecular biology and Peripheral blood mononuclear cell.
His Peripheral blood mononuclear cell research is multidisciplinary, relying on both Receptor and In vivo.
Donato Alarcón-Segovia works mostly in the field of Internal medicine, limiting it down to concerns involving Endocrinology and, occasionally, Lymphocyte.
In his study, Dermatology is strongly linked to Systemic disease, which falls under the umbrella field of Lupus erythematosus.
He most often published in these fields:
- Immunology (51.67%)
- Antibody (24.91%)
- Internal medicine (24.91%)
What were the highlights of his more recent work (between 1999-2020)?
- Immunology (51.67%)
- Internal medicine (24.91%)
- Lupus erythematosus (22.68%)
In recent papers he was focusing on the following fields of study:
His main research concerns Immunology, Internal medicine, Lupus erythematosus, Autoantibody and Antibody.
His Immunology research includes themes of Systemic lupus erythematosus, Disease and Allele frequency.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Endocrinology.
His Lupus erythematosus research incorporates elements of Single-nucleotide polymorphism and Locus.
His Autoantibody research is multidisciplinary, incorporating elements of Molecular biology, Protein S, Protein C and Pathogenesis.
His work on Antiphospholipid syndrome as part of general Antibody research is often related to Cardiolipin, thus linking different fields of science.
Between 1999 and 2020, his most popular works were:
- A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans (672 citations)
- Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus (423 citations)
- Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. (317 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Immune system
Donato Alarcón-Segovia focuses on Lupus erythematosus, Internal medicine, Immunology, Autoimmune disease and Genetics.
His research on Lupus erythematosus often connects related areas such as Systemic lupus erythematosus.
The study incorporates disciplines such as Gastroenterology and Surgery in addition to Internal medicine.
His biological study spans a wide range of topics, including Autoantibody and Autoimmunity.
His Autoantibody study is focused on Antibody in general.
His Connective tissue disease research incorporates themes from Chemotherapy, Biologic marker, Systemic disease, Immunopathology and Prednisone.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
